Patents by Inventor Margaret Mary Smith

Margaret Mary Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8293722
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: October 23, 2012
    Assignee: Sylvan Pharmaceuticals Pty Ltd.
    Inventors: David Cullis-Hill, Robert Logan Hannon, Christopher Bond Little, Margaret Mary Smith
  • Publication number: 20090111771
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Application
    Filed: December 8, 2008
    Publication date: April 30, 2009
    Applicant: Sylvan Pharmaceuticals Pty. Ltd. CAN 102 641 332
    Inventors: David Cullis-Hill, Robert Logan Hannon, Christopher Bond Little, Margaret Mary Smith
  • Publication number: 20080076723
    Abstract: The present invention provides a candidate compound that is suitable for use in methods of treating animals (preferably mammals) and in the preparation of a medicament, wherein the candidate compound down regulates Cathepsin K activity.
    Type: Application
    Filed: September 27, 2006
    Publication date: March 27, 2008
    Applicant: Sylvan Pharmaceuticals Pty Ltd.
    Inventors: David Cullis-Hill, Robert Logan Hannon, Christopher Bond Little, Margaret Mary Smith